BRIEF-Abbott's Humira wins EU approval for new use

Tue Nov 27, 2012 2:05am EST

Nov 27 (Reuters) - Abbott Laboratories : * Abbott's Humira (adalimumab) approved in Europe for severe active pediatric

Crohn's disease

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.